| BRAF | Serine/threonine-protein kinase B-raf |
| CCA | Cholangiocarcinoma |
| CifPK | Comprehensive inference of functional protein kinases |
| CCK-8 | Cell Counting Kit-8 |
| DEPs | Differentially expressed proteins |
| DRPs | Differentially regulated p-sites |
| DPPs | Differentially phosphorylated proteins |
| EMT | Epithelial mesenchymal transition |
| eCCA | Extrahepatic cholangiocarcinoma |
| FGFR2 | Fibroblast growth factor receptor 2 |
| FDA | Food and Drug Administration |
| HCC | Hepatocellular carcinoma |
| IC50 | Half-maximal inhibitory concentration |
| iCCA | Intrahepatic cholangiocarcinoma |
| LC-MS/MS | Liquid chromatography with tandem mass spectrometry |
| mTOR | Mammalian target of rapamycin |
| NATs | Normal adjacent tissues |
| PKs | Protein kinases |
| PKD/PRKD | Protein kinase D |
| PI3K | Phosphoinositide 3-kinase |
| PRKCI | Atypical protein kinase C iota |
| RTK | Receptor tyrosine kinase |
| Sp1 | Specificity protein 1 |
| siRNAs | Small interfering RNAs |
| 1-NA-PP1 | 1-naphthyl PP1 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.